These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1003 related items for PubMed ID: 12452996

  • 21. Squaric acid sensitization is not required for response in the treatment of alopecia areata.
    Vedak P, Kroshinsky D.
    J Am Acad Dermatol; 2015 Sep; 73(3):471-6. PubMed ID: 26282797
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
    Chua SH, Goh CL, Ang CB.
    Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
    [Abstract] [Full Text] [Related]

  • 25. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
    Inui S, Nakajima T, Toda N, Itami S.
    J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Treatment of alopecia areata with squaric acid dibutylester.
    Hill ND, Bunata K, Hebert AA.
    Clin Dermatol; 2015 Jun; 33(3):300-4. PubMed ID: 25889130
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Alopecia areata in children].
    Oranje AP, Peereboom-Wynia JD, de Raeymaecker DM.
    Tijdschr Kindergeneeskd; 1987 Oct; 55(5):177-81. PubMed ID: 3686512
    [Abstract] [Full Text] [Related]

  • 32. Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evaluation.
    Losol E, Şentürk N.
    Dermatol Ther; 2021 Jan; 34(1):e14726. PubMed ID: 33377267
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients.
    Sakai K, Fukushima S, Mizuhashi S, Jinnin M, Makino T, Inoue Y, Ihn H.
    Allergol Int; 2020 Apr; 69(2):274-278. PubMed ID: 31767273
    [Abstract] [Full Text] [Related]

  • 38. Nail Involvement in Alopecia Areata: A Questionnaire-based Survey on Clinical Signs, Impact on Quality of Life and Review of the Literature.
    Roest YBM, van Middendorp HT, Evers AWM, van de Kerkhof PCM, Pasch MC.
    Acta Derm Venereol; 2018 Feb 07; 98(2):212-217. PubMed ID: 28967977
    [Abstract] [Full Text] [Related]

  • 39. Screening Guidelines for Thyroid Function in Children With Alopecia Areata.
    Patel D, Li P, Bauer AJ, Castelo-Soccio L.
    JAMA Dermatol; 2017 Dec 01; 153(12):1307-1310. PubMed ID: 28973128
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.